| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA478014
Max Phase: Preclinical
Molecular Formula: C25H40N2O3
Molecular Weight: 416.61
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCCCCCN1CCc2c(C)cc(C)c(NC(=O)C(C)(C)CCC(=O)O)c21
Standard InChI: InChI=1S/C25H40N2O3/c1-6-7-8-9-10-11-15-27-16-13-20-18(2)17-19(3)22(23(20)27)26-24(30)25(4,5)14-12-21(28)29/h17H,6-16H2,1-5H3,(H,26,30)(H,28,29)
Standard InChI Key: NEQHFLHCAZXFPF-UHFFFAOYSA-N
Associated Targets(Human)
Acyl coenzyme A:cholesterol acyltransferase 1 857 Activities
Associated Targets(non-human)
Acyl-CoA:cholesterol acyltransferase 1121 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Brain 4256 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Rattus norvegicus 775804 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 416.61 | Molecular Weight (Monoisotopic): 416.3039 | AlogP: 5.86 | #Rotatable Bonds: 12 |
| Polar Surface Area: 69.64 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 4.42 | CX Basic pKa: 3.73 | CX LogP: 6.42 | CX LogD: 3.87 |
| Aromatic Rings: 1 | Heavy Atoms: 30 | QED Weighted: 0.42 | Np Likeness Score: -0.44 |
References
| 1. Takahashi K, Kasai M, Ohta M, Shoji Y, Kunishiro K, Kanda M, Kurahashi K, Shirahase H.. (2008) Novel indoline-based acyl-CoA:cholesterol acyltransferase inhibitor with antiperoxidative activity: improvement of physicochemical properties and biological activities by introduction of carboxylic acid., 51 (15): [PMID:18620381] [10.1021/jm800248r] |
Source
Source(1):